IFM Investors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16M | Buy |
174,744
+18,516
| +12% | +$1.62M | 0.11% | 175 |
|
|
2026
Q1 | $13.3M | Sell |
156,228
-3,681
| -2% | -$328K | 0.11% | 173 |
|
|
2025
Q4 | $12.6M | Sell |
159,909
-6,225
| -4% | -$488K | 0.11% | 176 |
|
|
2025
Q3 | $13.2M | Buy |
166,134
+1,846
| +1% | +$157K | 0.12% | 160 |
|
|
2025
Q2 | $14.9M | Buy |
164,288
+4,879
| +3% | +$445K | 0.14% | 133 |
|
|
2025
Q1 | $14.9M | Buy |
159,409
+439
| +0.3% | +$39.3K | 0.16% | 118 |
|
|
2024
Q4 | $14.5M | Sell |
158,970
-10,729
| -6% | -$1.02M | 0.15% | 130 |
|
|
2024
Q3 | $17.6M | Buy |
169,699
+6,330
| +4% | +$645K | 0.17% | 113 |
|
|
2024
Q2 | $15.9M | Buy |
163,369
+212
| +0.1% | +$19.6K | 0.16% | 115 |
|
|
2024
Q1 | $14.7M | Sell |
163,157
-1,213
| -0.7% | -$103K | 0.16% | 118 |
|
|
2023
Q4 | $13.1M | Sell |
164,370
-1,129
| -0.7% | -$84.9K | 0.16% | 121 |
|
|
2023
Q3 | $11.8M | Buy |
165,499
+5,493
| +3% | +$411K | 0.15% | 129 |
|
|
2023
Q2 | $12.3M | Buy |
160,006
+7,637
| +5% | +$591K | 0.16% | 126 |
|
|
2023
Q1 | $11.5M | Sell |
152,369
-1,624
| -1% | -$121K | 0.17% | 115 |
|
|
2022
Q4 | $12.1M | Buy |
153,993
+4,785
| +3% | +$359K | 0.2% | 103 |
|
|
2022
Q3 | $10.5M | Buy |
149,208
+4,079
| +3% | +$320K | 0.19% | 110 |
|
|
2022
Q2 | $11.6M | Buy |
145,129
+11,864
| +9% | +$928K | 0.2% | 99 |
|
|
2022
Q1 | $10.1M | Buy |
133,265
+25,779
| +24% | +$2.04M | 0.16% | 130 |
|
|
2021
Q4 | $9.17M | Sell |
107,486
-1,992
| -2% | -$156K | 0.17% | 116 |
|
|
2021
Q3 | $8.27M | Buy |
109,478
+426
| +0.4% | +$33.8K | 0.17% | 116 |
|
|
2021
Q2 | $8.87M | Buy |
109,052
+17,167
| +19% | +$1.4M | 0.18% | 117 |
|
|
2021
Q1 | $7.24M | Buy |
91,885
+13,167
| +17% | +$1.03M | 0.19% | 109 |
|
|
2020
Q4 | $6.73M | Buy |
78,718
+10,766
| +16% | +$890K | 0.21% | 96 |
|
|
2020
Q3 | $5.24M | Buy |
67,952
+7,534
| +12% | +$574K | 0.22% | 92 |
|
|
2020
Q2 | $4.43M | Sell |
60,418
-20,653
| -25% | -$1.47M | 0.23% | 91 |
|
|
2020
Q1 | $5.4M | Sell |
81,071
-2,840
| -3% | -$200K | 0.24% | 96 |
|
|
2019
Q4 | $5.78M | Sell |
83,911
-3,863
| -4% | -$263K | 0.2% | 108 |
|
|
2019
Q3 | $6.45M | Buy |
87,774
+30,019
| +52% | +$2.18M | 0.24% | 90 |
|
|
2019
Q2 | $4.14M | Buy |
57,755
+4,206
| +8% | +$299K | 0.24% | 90 |
|
|
2019
Q1 | $3.67M | Buy |
53,549
+6,036
| +13% | +$390K | 0.24% | 94 |
|
|
2018
Q4 | $2.83M | Buy |
47,513
+4,180
| +10% | +$262K | 0.23% | 94 |
|
|
2018
Q3 | $2.9M | Buy |
43,333
+5,977
| +16% | +$398K | 0.22% | 99 |
|
|
2018
Q2 | $2.42M | Buy |
37,356
+11,208
| +43% | +$733K | 0.23% | 100 |
|
|
2018
Q1 | $1.87M | Buy |
26,148
+2,527
| +11% | +$182K | 0.27% | 83 |
|
|
2017
Q4 | $1.78M | Sell |
23,621
-121
| -0.5% | -$8.84K | 0.28% | 79 |
|
|
2017
Q3 | $1.73M | Buy |
23,742
+745
| +3% | +$53.7K | 0.29% | 79 |
|
|
2017
Q2 | $1.71M | Buy |
22,997
+5,890
| +34% | +$437K | 0.31% | 74 |
|
|
2017
Q1 | $1.25M | Buy |
17,107
+6,312
| +58% | +$442K | 0.32% | 72 |
|
|
2016
Q4 | $706K | Buy |
+10,795
| New | +$740K | 0.33% | 75 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
IFM Investors's CL Position: Q2 2026 in Review
IFM Investors increased its Colgate-Palmolive (CL) stake by 12% in Q2 2026, buying an estimated $1.62M and bringing the position to 174,744 shares worth $16M. The position accounts for 0.11% of the portfolio, ranked #175.
IFM Investors first reported a position in CL in Q4 2016 and has held it in 39 quarters since. The position peaked at $17.6M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- IFM Investors held 174,744 shares of Colgate-Palmolive worth $16M as of Q2 2026.
- IFM Investors bought 18,516 Colgate-Palmolive shares in Q2 2026, an estimated $1.62M.
- Colgate-Palmolive made up 0.11% of IFM Investors's portfolio in Q2 2026, its #175 holding.
- IFM Investors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's Colgate-Palmolive position peaked at $17.6M in Q3 2024.
- 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.